Allergen immunotherapy is a cornerstone in the treatment of allergic children. The clinical
efficiency relies on a well‐defined immunologic mechanism promoting regulatory T cells and …

Allergen-specific immunotherapy (AIT) is currently recognized as a clinically effective
treatment for allergic diseases, with a unique disease-modifying effect. AIT was introduced in …

Allergic diseases are common and frequently coexist. Allergen immunotherapy (AIT) is a
disease‐modifying treatment for IgE‐mediated allergic disease with effects beyond …

This document builds on the previous Joint Task Force document ''Allergen immunotherapy:
a practice parameter second update''published in the Journal of Allergy and Clinical …

Allergen-specific immunotherapy is recognized as a highly effective practice in the treatment
of patients with severe allergic rhinitis and/or asthma and is recommended by World Health …

Abstract Allergen Specific Immunotherapy (SIT) for respiratory allergic diseases is able to
significantly improve symptoms as well as reduce the need for symptomatic medication, but …

The Allergic Rhinitis and its Impact on Asthma document was first published in 2001. Since
then, new data on specific immunotherapy have appeared. This review is intended as an …

Background There is a need to establish the effectiveness, cost‐effectiveness, and safety of
allergen immunotherapy (AIT) for the prevention of allergic disease. Methods Two reviewers …

Background Guidelines and position papers indicate that allergen immunotherapy (AIT) is
the only disease‐modifying treatment, including prevention of the onset of new allergen …

The allergist's community has recently celebrated 100 year of Allergen Immunotherapy (AIT).
Unfortunately the implemention of this treatment is still impaired by some challenges. With …